<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-06-29T08:14:09Z</responseDate><request verb="GetRecord" identifier="oai:docta.ucm.es:20.500.14352/45198" metadataPrefix="oai_dc">https://docta.ucm.es/rest/oai/request</request><GetRecord><record><header><identifier>oai:docta.ucm.es:20.500.14352/45198</identifier><datestamp>2024-04-10T14:17:02Z</datestamp><setSpec>com_20.500.14352_14</setSpec><setSpec>col_20.500.14352_15</setSpec></header><metadata><oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
   <dc:title>Characterization of the immune response induced by a commercially available inactivated bluetongue virus serotype 1 vaccine in sheep</dc:title>
   <dc:creator>Pérez de Diego, Ana Cristina</dc:creator>
   <dc:creator>Sánchez Cordón, Pedro José</dc:creator>
   <dc:creator>Heras, Ana Isabel de las</dc:creator>
   <dc:creator>Sánchez-Vizcaíno Rodríguez, José Manuel</dc:creator>
   <dc:subject>Veterinaria</dc:subject>
   <dc:subject>3109 Ciencias Veterinarias</dc:subject>
   <dc:description>The protective immune response generated by a commercial monovalent inactivated vaccine against bluetongue virus serotype 1 (BTV1) was studied. Five sheep were vaccinated, boost-vaccinated, and then challenged against BTV1 ALG/2006. RT-PCR did not detect viremia at any time during the experiment. Except a temperature increase observed after the initial and boost vaccinations, no clinical signs or lesions were observed. A specific and protective antibody response checked by ELISA was induced after vaccination and boost vaccination. This specific antibody response was associated with a significant increase in B lymphocytes confirmed by flow cytometry, while significant increases were not observed in T lymphocyte subpopulations (CD4(+), CD8(+), and WC1(+)), CD25(+) regulatory cells, or CD14(+) monocytes. After challenge with BTV1, the antibody response was much higher than during the boost vaccination period, and it was associated with a significant increase in B lymphocytes, CD14(+) monocytes, CD25(+) regulatory cells, and CD8(+) cytotoxic T lymphocytes.</dc:description>
   <dc:description>Ministerio de Ciencia e Innovación (MICINN)</dc:description>
   <dc:description>Unión Europea. FP6</dc:description>
   <dc:description>Centro de Vigilancia Sanitaria Veterinaria (VISAVET)</dc:description>
   <dc:description>TRUE</dc:description>
   <dc:description>pub</dc:description>
   <dc:date>2023-06-20T04:21:08Z</dc:date>
   <dc:date>2023-06-20T04:21:08Z</dc:date>
   <dc:date>2012</dc:date>
   <dc:type>journal article</dc:type>
   <dc:identifier>https://hdl.handle.net/20.500.14352/45198</dc:identifier>
   <dc:identifier>1537-744X</dc:identifier>
   <dc:identifier>10.1100/2012/147158</dc:identifier>
   <dc:language>eng</dc:language>
   <dc:relation>AGL2009-13174-C02-01</dc:relation>
   <dc:relation>BTVAC (44211)</dc:relation>
   <dc:rights>Atribución 3.0 España</dc:rights>
   <dc:rights>https://creativecommons.org/licenses/by/3.0/es/</dc:rights>
   <dc:rights>open access</dc:rights>
   <dc:format>application/pdf</dc:format>
   <dc:publisher>Hindawi Publishing Corporation</dc:publisher>
</oai_dc:dc></metadata></record></GetRecord></OAI-PMH>